Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 6.3 | ug/ml | 11170636 |
NPT521 | Cell Line | RBL-2H3 | Rattus norvegicus | IC50 | > | 500000 | nM | 14510616 |
NPT149 | Individual Protein | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 3548.1 | nM | PubChem BioAssay data set |
NPT1161 | Cell Line | CHO | Cricetulus griseus | Potency | = | 79432.8 | nM | PubChem BioAssay data set |
NPT93 | Individual Protein | Survival motor neuron protein | Homo sapiens | Potency | = | 10000 | nM | PubChem BioAssay data set |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Potency | = | 4466.8 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 4466.8 | nM | PubChem BioAssay data set |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 25118.9 | nM | PubChem BioAssay data set |
NPT53 | Individual Protein | 4'-phosphopantetheinyl transferase ffp | Bacillus subtilis | Potency | = | 35481.3 | nM | PubChem BioAssay data set |
NPT442 | Individual Protein | Ferritin light chain | Equus caballus | Potency | = | 50118.7 | nM | PubChem BioAssay data set |
NPT282 | Individual Protein | MAP kinase ERK2 | Homo sapiens | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
NPT714 | Individual Protein | Fructose-bisphosphate aldolase A | Oryctolagus cuniculus | Potency | = | 125892.5 | nM | PubChem BioAssay data set |
NPT55 | Individual Protein | Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | = | 35481.3 | nM | PubChem BioAssay data set |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT55 | Individual Protein | Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | = | 7924.5 | nM | PubChem BioAssay data set |
NPT151 | Individual Protein | 15-hydroxyprostaglandin dehydrogenase [NAD+] | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT501 | Individual Protein | Alpha-galactosidase A | Homo sapiens | Potency | = | 31622.8 | nM | PubChem BioAssay data set |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 7943.3 | nM | PubChem BioAssay data set |
NPT443 | Individual Protein | Histone acetyltransferase GCN5 | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | 89125.1 | nM | PubChem BioAssay data set | |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 1200 | nM | 15240100 |
NPT587 | Tissue | Liver microsome | Rattus norvegicus | IC50 | = | 40 | ug/ml | 10.1007/s00044-012-0423-1 |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI | < | 50 | % | 10.1007/s00044-012-0423-1 |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI | < | 50 | % | 10.1007/s00044-012-0423-1 |
NPT65 | Cell Line | HepG2 | Homo sapiens | GI | < | 50 | % | 10.1007/s00044-012-0423-1 |
NPT2 | Others | Unspecified | Potency | 14581 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 20596.2 | nM | PubChem BioAssay data set | ||
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 129.7 | % | 23571415 |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 187.63 | % | 23571415 |
NPT2 | Others | Unspecified | Potency | 7079.5 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC77955 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9416 | High Similarity | NPC113089 |
0.9348 | High Similarity | NPC136278 |
0.9343 | High Similarity | NPC9966 |
0.9343 | High Similarity | NPC70853 |
0.9275 | High Similarity | NPC23955 |
0.927 | High Similarity | NPC29536 |
0.9214 | High Similarity | NPC299923 |
0.9214 | High Similarity | NPC205522 |
0.9209 | High Similarity | NPC471590 |
0.9167 | High Similarity | NPC301717 |
0.9147 | High Similarity | NPC2771 |
0.9143 | High Similarity | NPC40818 |
0.9143 | High Similarity | NPC110639 |
0.9143 | High Similarity | NPC106461 |
0.9143 | High Similarity | NPC215932 |
0.9143 | High Similarity | NPC310259 |
0.9143 | High Similarity | NPC14958 |
0.9137 | High Similarity | NPC293201 |
0.913 | High Similarity | NPC124467 |
0.913 | High Similarity | NPC214919 |
0.9078 | High Similarity | NPC12200 |
0.9078 | High Similarity | NPC85233 |
0.9014 | High Similarity | NPC10304 |
0.9014 | High Similarity | NPC63256 |
0.9014 | High Similarity | NPC195202 |
0.9014 | High Similarity | NPC261548 |
0.9007 | High Similarity | NPC283002 |
0.9007 | High Similarity | NPC302408 |
0.9007 | High Similarity | NPC231013 |
0.8993 | High Similarity | NPC185607 |
0.8978 | High Similarity | NPC44573 |
0.8958 | High Similarity | NPC308451 |
0.8951 | High Similarity | NPC69752 |
0.8951 | High Similarity | NPC137062 |
0.8951 | High Similarity | NPC52005 |
0.8951 | High Similarity | NPC159103 |
0.8951 | High Similarity | NPC223579 |
0.8951 | High Similarity | NPC287101 |
0.8951 | High Similarity | NPC183950 |
0.8944 | High Similarity | NPC62536 |
0.8944 | High Similarity | NPC117463 |
0.8944 | High Similarity | NPC470511 |
0.8944 | High Similarity | NPC33265 |
0.8939 | High Similarity | NPC125887 |
0.8936 | High Similarity | NPC165512 |
0.8897 | High Similarity | NPC55205 |
0.8897 | High Similarity | NPC39732 |
0.8897 | High Similarity | NPC40033 |
0.8897 | High Similarity | NPC60972 |
0.8889 | High Similarity | NPC189270 |
0.8889 | High Similarity | NPC50728 |
0.8889 | High Similarity | NPC306821 |
0.8889 | High Similarity | NPC5840 |
0.8889 | High Similarity | NPC201547 |
0.8889 | High Similarity | NPC259058 |
0.8889 | High Similarity | NPC166753 |
0.8881 | High Similarity | NPC476342 |
0.8881 | High Similarity | NPC120464 |
0.8873 | High Similarity | NPC216314 |
0.8873 | High Similarity | NPC120924 |
0.8873 | High Similarity | NPC195919 |
0.8864 | High Similarity | NPC298884 |
0.8836 | High Similarity | NPC472408 |
0.8836 | High Similarity | NPC279930 |
0.8836 | High Similarity | NPC186507 |
0.8828 | High Similarity | NPC125062 |
0.8828 | High Similarity | NPC208043 |
0.8828 | High Similarity | NPC472535 |
0.8828 | High Similarity | NPC474170 |
0.8828 | High Similarity | NPC474388 |
0.8828 | High Similarity | NPC252933 |
0.8828 | High Similarity | NPC226973 |
0.8828 | High Similarity | NPC54394 |
0.8828 | High Similarity | NPC200740 |
0.8828 | High Similarity | NPC236769 |
0.8819 | High Similarity | NPC181250 |
0.8819 | High Similarity | NPC238366 |
0.8819 | High Similarity | NPC177298 |
0.8819 | High Similarity | NPC48479 |
0.8819 | High Similarity | NPC328119 |
0.8811 | High Similarity | NPC108406 |
0.8794 | High Similarity | NPC476054 |
0.8786 | High Similarity | NPC58229 |
0.8776 | High Similarity | NPC20830 |
0.8776 | High Similarity | NPC256612 |
0.8776 | High Similarity | NPC284353 |
0.8767 | High Similarity | NPC198826 |
0.8767 | High Similarity | NPC212678 |
0.8767 | High Similarity | NPC279989 |
0.8767 | High Similarity | NPC134677 |
0.8767 | High Similarity | NPC239128 |
0.8767 | High Similarity | NPC83508 |
0.8767 | High Similarity | NPC292460 |
0.8767 | High Similarity | NPC100887 |
0.8767 | High Similarity | NPC301323 |
0.8767 | High Similarity | NPC25270 |
0.8767 | High Similarity | NPC293183 |
0.8767 | High Similarity | NPC156222 |
0.8767 | High Similarity | NPC256283 |
0.8767 | High Similarity | NPC188203 |
0.8767 | High Similarity | NPC301123 |
0.8767 | High Similarity | NPC82325 |
0.8767 | High Similarity | NPC166201 |
0.8767 | High Similarity | NPC222830 |
0.8767 | High Similarity | NPC131624 |
0.8767 | High Similarity | NPC71334 |
0.8767 | High Similarity | NPC275722 |
0.8767 | High Similarity | NPC241498 |
0.8767 | High Similarity | NPC162313 |
0.8767 | High Similarity | NPC68882 |
0.8767 | High Similarity | NPC275836 |
0.8767 | High Similarity | NPC57030 |
0.8767 | High Similarity | NPC120163 |
0.8767 | High Similarity | NPC187498 |
0.8759 | High Similarity | NPC177839 |
0.8759 | High Similarity | NPC219330 |
0.8741 | High Similarity | NPC12377 |
0.8732 | High Similarity | NPC182842 |
0.8716 | High Similarity | NPC265511 |
0.8707 | High Similarity | NPC69394 |
0.8707 | High Similarity | NPC472915 |
0.8707 | High Similarity | NPC183878 |
0.8707 | High Similarity | NPC145379 |
0.8707 | High Similarity | NPC86485 |
0.8707 | High Similarity | NPC476289 |
0.8707 | High Similarity | NPC176775 |
0.8707 | High Similarity | NPC236223 |
0.8707 | High Similarity | NPC128961 |
0.8707 | High Similarity | NPC78326 |
0.8707 | High Similarity | NPC47781 |
0.8707 | High Similarity | NPC22519 |
0.8707 | High Similarity | NPC280937 |
0.8707 | High Similarity | NPC160951 |
0.8707 | High Similarity | NPC255350 |
0.8707 | High Similarity | NPC231018 |
0.8707 | High Similarity | NPC179126 |
0.8707 | High Similarity | NPC274327 |
0.8707 | High Similarity | NPC270620 |
0.8699 | High Similarity | NPC133953 |
0.8699 | High Similarity | NPC31363 |
0.8699 | High Similarity | NPC28274 |
0.8699 | High Similarity | NPC149614 |
0.8699 | High Similarity | NPC50403 |
0.8699 | High Similarity | NPC76376 |
0.8699 | High Similarity | NPC260895 |
0.8699 | High Similarity | NPC117579 |
0.869 | High Similarity | NPC270465 |
0.869 | High Similarity | NPC87125 |
0.869 | High Similarity | NPC474648 |
0.8686 | High Similarity | NPC292998 |
0.8681 | High Similarity | NPC46941 |
0.8681 | High Similarity | NPC474999 |
0.8681 | High Similarity | NPC168803 |
0.8676 | High Similarity | NPC284424 |
0.8676 | High Similarity | NPC278556 |
0.8671 | High Similarity | NPC70136 |
0.8662 | High Similarity | NPC119663 |
0.8658 | High Similarity | NPC19097 |
0.8658 | High Similarity | NPC476981 |
0.8649 | High Similarity | NPC241774 |
0.8649 | High Similarity | NPC26227 |
0.8649 | High Similarity | NPC122623 |
0.8649 | High Similarity | NPC189960 |
0.8649 | High Similarity | NPC32557 |
0.8649 | High Similarity | NPC163780 |
0.8649 | High Similarity | NPC50715 |
0.8649 | High Similarity | NPC183597 |
0.8649 | High Similarity | NPC138360 |
0.8649 | High Similarity | NPC234255 |
0.8649 | High Similarity | NPC167815 |
0.8649 | High Similarity | NPC201136 |
0.8649 | High Similarity | NPC2928 |
0.8649 | High Similarity | NPC2476 |
0.8649 | High Similarity | NPC196439 |
0.8649 | High Similarity | NPC255807 |
0.8649 | High Similarity | NPC44079 |
0.8649 | High Similarity | NPC92659 |
0.8649 | High Similarity | NPC34725 |
0.8649 | High Similarity | NPC227325 |
0.8649 | High Similarity | NPC213622 |
0.8649 | High Similarity | NPC208197 |
0.8649 | High Similarity | NPC128863 |
0.8649 | High Similarity | NPC146165 |
0.8649 | High Similarity | NPC4455 |
0.8649 | High Similarity | NPC276059 |
0.8649 | High Similarity | NPC201451 |
0.8649 | High Similarity | NPC31018 |
0.8649 | High Similarity | NPC280339 |
0.8647 | High Similarity | NPC474264 |
0.8643 | High Similarity | NPC223336 |
0.8639 | High Similarity | NPC123886 |
0.8639 | High Similarity | NPC236637 |
0.8639 | High Similarity | NPC302950 |
0.8639 | High Similarity | NPC257648 |
0.8639 | High Similarity | NPC142540 |
0.8639 | High Similarity | NPC471982 |
0.8639 | High Similarity | NPC219582 |
0.8639 | High Similarity | NPC477231 |
0.8633 | High Similarity | NPC254741 |
0.863 | High Similarity | NPC184136 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC77955 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8707 | High Similarity | NPD2801 | Approved |
0.8649 | High Similarity | NPD3817 | Phase 2 |
0.8639 | High Similarity | NPD1934 | Approved |
0.8601 | High Similarity | NPD1511 | Approved |
0.85 | High Similarity | NPD2796 | Approved |
0.8483 | Intermediate Similarity | NPD1512 | Approved |
0.8478 | Intermediate Similarity | NPD1933 | Approved |
0.8421 | Intermediate Similarity | NPD5494 | Approved |
0.8344 | Intermediate Similarity | NPD3882 | Suspended |
0.8333 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.8271 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.8214 | Intermediate Similarity | NPD447 | Suspended |
0.8168 | Intermediate Similarity | NPD5536 | Phase 2 |
0.8163 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.8129 | Intermediate Similarity | NPD1247 | Approved |
0.8129 | Intermediate Similarity | NPD2313 | Discontinued |
0.8117 | Intermediate Similarity | NPD919 | Approved |
0.8101 | Intermediate Similarity | NPD3818 | Discontinued |
0.8095 | Intermediate Similarity | NPD6799 | Approved |
0.8089 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.8089 | Intermediate Similarity | NPD6166 | Phase 2 |
0.8089 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.8085 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.805 | Intermediate Similarity | NPD7054 | Approved |
0.8042 | Intermediate Similarity | NPD3748 | Approved |
0.8042 | Intermediate Similarity | NPD1510 | Phase 2 |
0.8025 | Intermediate Similarity | NPD3926 | Phase 2 |
0.8 | Intermediate Similarity | NPD1549 | Phase 2 |
0.8 | Intermediate Similarity | NPD7472 | Approved |
0.7986 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7971 | Intermediate Similarity | NPD2798 | Approved |
0.7933 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7931 | Intermediate Similarity | NPD2346 | Discontinued |
0.7931 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.7931 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.7922 | Intermediate Similarity | NPD5402 | Approved |
0.7919 | Intermediate Similarity | NPD5401 | Approved |
0.7917 | Intermediate Similarity | NPD2799 | Discontinued |
0.7895 | Intermediate Similarity | NPD4380 | Phase 2 |
0.7888 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7887 | Intermediate Similarity | NPD1240 | Approved |
0.7863 | Intermediate Similarity | NPD1241 | Discontinued |
0.7862 | Intermediate Similarity | NPD2935 | Discontinued |
0.7857 | Intermediate Similarity | NPD7819 | Suspended |
0.7857 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.7853 | Intermediate Similarity | NPD7808 | Phase 3 |
0.784 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7829 | Intermediate Similarity | NPD3226 | Approved |
0.7823 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7821 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7815 | Intermediate Similarity | NPD5403 | Approved |
0.78 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7792 | Intermediate Similarity | NPD6801 | Discontinued |
0.7791 | Intermediate Similarity | NPD7251 | Discontinued |
0.7778 | Intermediate Similarity | NPD6599 | Discontinued |
0.7778 | Intermediate Similarity | NPD1607 | Approved |
0.777 | Intermediate Similarity | NPD3750 | Approved |
0.7756 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7754 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7744 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7736 | Intermediate Similarity | NPD6232 | Discontinued |
0.7733 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7727 | Intermediate Similarity | NPD6385 | Approved |
0.7727 | Intermediate Similarity | NPD6386 | Approved |
0.7707 | Intermediate Similarity | NPD7075 | Discontinued |
0.7703 | Intermediate Similarity | NPD1243 | Approved |
0.7702 | Intermediate Similarity | NPD7473 | Discontinued |
0.7697 | Intermediate Similarity | NPD920 | Approved |
0.7687 | Intermediate Similarity | NPD2344 | Approved |
0.7651 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7643 | Intermediate Similarity | NPD1203 | Approved |
0.7639 | Intermediate Similarity | NPD4307 | Phase 2 |
0.7635 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7619 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7613 | Intermediate Similarity | NPD7411 | Suspended |
0.7607 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7594 | Intermediate Similarity | NPD5283 | Phase 1 |
0.7591 | Intermediate Similarity | NPD17 | Approved |
0.7589 | Intermediate Similarity | NPD1019 | Discontinued |
0.7571 | Intermediate Similarity | NPD1876 | Approved |
0.7566 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7564 | Intermediate Similarity | NPD6844 | Discontinued |
0.7554 | Intermediate Similarity | NPD3972 | Approved |
0.7554 | Intermediate Similarity | NPD9717 | Approved |
0.755 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7535 | Intermediate Similarity | NPD9494 | Approved |
0.7518 | Intermediate Similarity | NPD3266 | Approved |
0.7518 | Intermediate Similarity | NPD3267 | Approved |
0.7517 | Intermediate Similarity | NPD943 | Approved |
0.7516 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7483 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7483 | Intermediate Similarity | NPD2309 | Approved |
0.747 | Intermediate Similarity | NPD6559 | Discontinued |
0.7468 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.745 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7432 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7429 | Intermediate Similarity | NPD1608 | Approved |
0.7421 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7417 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7413 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7397 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7397 | Intermediate Similarity | NPD1613 | Approved |
0.7394 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7379 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7379 | Intermediate Similarity | NPD411 | Approved |
0.7379 | Intermediate Similarity | NPD6798 | Discontinued |
0.7368 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7346 | Intermediate Similarity | NPD6959 | Discontinued |
0.7338 | Intermediate Similarity | NPD4661 | Approved |
0.7338 | Intermediate Similarity | NPD4662 | Approved |
0.7333 | Intermediate Similarity | NPD2353 | Approved |
0.7333 | Intermediate Similarity | NPD2355 | Clinical (unspecified phase) |
0.7305 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7292 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7273 | Intermediate Similarity | NPD1470 | Approved |
0.7273 | Intermediate Similarity | NPD2797 | Approved |
0.7267 | Intermediate Similarity | NPD3749 | Approved |
0.7266 | Intermediate Similarity | NPD1651 | Approved |
0.7262 | Intermediate Similarity | NPD7039 | Approved |
0.7262 | Intermediate Similarity | NPD7038 | Approved |
0.726 | Intermediate Similarity | NPD3268 | Approved |
0.7256 | Intermediate Similarity | NPD5242 | Approved |
0.7255 | Intermediate Similarity | NPD3887 | Approved |
0.7239 | Intermediate Similarity | NPD8127 | Discontinued |
0.7237 | Intermediate Similarity | NPD2800 | Approved |
0.7234 | Intermediate Similarity | NPD1201 | Approved |
0.7234 | Intermediate Similarity | NPD3705 | Approved |
0.723 | Intermediate Similarity | NPD230 | Phase 1 |
0.723 | Intermediate Similarity | NPD6355 | Discontinued |
0.7226 | Intermediate Similarity | NPD3688 | Clinical (unspecified phase) |
0.7226 | Intermediate Similarity | NPD3146 | Approved |
0.7219 | Intermediate Similarity | NPD2343 | Clinical (unspecified phase) |
0.7212 | Intermediate Similarity | NPD7784 | Clinical (unspecified phase) |
0.7212 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7211 | Intermediate Similarity | NPD6233 | Phase 2 |
0.7203 | Intermediate Similarity | NPD3225 | Approved |
0.72 | Intermediate Similarity | NPD7033 | Discontinued |
0.7192 | Intermediate Similarity | NPD3027 | Phase 3 |
0.719 | Intermediate Similarity | NPD4109 | Clinical (unspecified phase) |
0.719 | Intermediate Similarity | NPD4110 | Phase 3 |
0.7183 | Intermediate Similarity | NPD2981 | Phase 2 |
0.717 | Intermediate Similarity | NPD6873 | Phase 2 |
0.7162 | Intermediate Similarity | NPD3140 | Approved |
0.7162 | Intermediate Similarity | NPD3142 | Approved |
0.7143 | Intermediate Similarity | NPD5977 | Approved |
0.7143 | Intermediate Similarity | NPD2354 | Approved |
0.7143 | Intermediate Similarity | NPD5353 | Approved |
0.7143 | Intermediate Similarity | NPD5585 | Approved |
0.7143 | Intermediate Similarity | NPD5978 | Approved |
0.7143 | Intermediate Similarity | NPD1296 | Phase 2 |
0.7143 | Intermediate Similarity | NPD3764 | Approved |
0.7134 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7133 | Intermediate Similarity | NPD2982 | Phase 2 |
0.7133 | Intermediate Similarity | NPD2983 | Phase 2 |
0.7132 | Intermediate Similarity | NPD5535 | Approved |
0.7126 | Intermediate Similarity | NPD3751 | Discontinued |
0.7126 | Intermediate Similarity | NPD2163 | Approved |
0.7125 | Intermediate Similarity | NPD6279 | Approved |
0.7125 | Intermediate Similarity | NPD6280 | Approved |
0.7124 | Intermediate Similarity | NPD2654 | Approved |
0.7113 | Intermediate Similarity | NPD1281 | Approved |
0.7099 | Intermediate Similarity | NPD5019 | Clinical (unspecified phase) |
0.7089 | Intermediate Similarity | NPD1653 | Approved |
0.7086 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.7076 | Intermediate Similarity | NPD8312 | Approved |
0.7076 | Intermediate Similarity | NPD8313 | Approved |
0.7075 | Intermediate Similarity | NPD7095 | Approved |
0.7071 | Intermediate Similarity | NPD1894 | Discontinued |
0.7071 | Intermediate Similarity | NPD9545 | Approved |
0.7071 | Intermediate Similarity | NPD1548 | Phase 1 |
0.707 | Intermediate Similarity | NPD5049 | Phase 3 |
0.707 | Intermediate Similarity | NPD6273 | Approved |
0.707 | Intermediate Similarity | NPD1940 | Clinical (unspecified phase) |
0.7063 | Intermediate Similarity | NPD5889 | Approved |
0.7063 | Intermediate Similarity | NPD1481 | Phase 2 |
0.7063 | Intermediate Similarity | NPD5890 | Approved |
0.7059 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7059 | Intermediate Similarity | NPD228 | Approved |
0.7055 | Intermediate Similarity | NPD2861 | Phase 2 |
0.705 | Intermediate Similarity | NPD9493 | Approved |
0.7048 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7047 | Intermediate Similarity | NPD2979 | Phase 3 |
0.7044 | Intermediate Similarity | NPD7458 | Discontinued |
0.7044 | Intermediate Similarity | NPD2649 | Approved |
0.7044 | Intermediate Similarity | NPD2651 | Approved |
0.7042 | Intermediate Similarity | NPD3496 | Discontinued |
0.7037 | Intermediate Similarity | NPD4288 | Approved |
0.7032 | Intermediate Similarity | NPD3295 | Clinical (unspecified phase) |
0.7032 | Intermediate Similarity | NPD6190 | Approved |
0.7024 | Intermediate Similarity | NPD7893 | Clinical (unspecified phase) |
0.7019 | Intermediate Similarity | NPD37 | Approved |
0.7015 | Intermediate Similarity | NPD1358 | Approved |
0.7007 | Intermediate Similarity | NPD5752 | Clinical (unspecified phase) |
0.7006 | Intermediate Similarity | NPD2532 | Approved |
0.7006 | Intermediate Similarity | NPD2533 | Approved |
0.7006 | Intermediate Similarity | NPD2534 | Approved |
0.7006 | Intermediate Similarity | NPD2403 | Approved |
0.7006 | Intermediate Similarity | NPD7422 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD6585 | Discontinued |
PubChem CID   | 688674 |
ChEMBL   | CHEMBL91153 |
ZINC   |
Molecular Weight:   | 282.09 |
ALogP:   | -0.6072 |
MLogP:   | 2.89 |
XLogP:   | 3.779 |
# Rotatable Bonds:   | 5 |
Polar Surface Area:   | 44.76 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 0 |
# Rings:   | 3 |
# Heavy Atoms:   | 21 |